Intravitreal bevacizumab for retinopathy of prematurity as first line or rescue therapy with focal laser treatment. A case series

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 25, Issue 11, 2012, Pages 2194-2197

  Dani, Carlo ^a   Frosini, Saverio ^b   Fortunato, Pina ^c   Bertini, Giovanna ^a   Pratesi, Simone ^a   Pollazzi, Liliana ^d   Caputo, Roberto ^c   La Torre, Agostino ^b  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d Orthoptist Ophthalmology Assistant   (Italy)

Author keywords

Anti VEGF; Bevacizumab; Preterm infant; Retinopathy of prematurity

Indexed keywords

BEVACIZUMAB;

ABSENCE OF SIDE EFFECTS; AGGRESSIVE POSTERIOR RETROLENTAL FIBROPLASIA; ARTICLE; CASE STUDY; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; INFANT; INTRAOCULAR HEMORRHAGE; LASER COAGULATION; MALE; MONOTHERAPY; MYOPIA; PRIORITY JOURNAL; RECURRENT DISEASE; REMISSION; RETINA NEOVASCULARIZATION; RETROLENTAL FIBROPLASIA; RETROSPECTIVE STUDY; STRABISMUS; SYSTEMIC DISEASE; TREATMENT OUTCOME;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; CASE-CONTROL STUDIES; COHORT STUDIES; COMBINED MODALITY THERAPY; COMPASSIONATE USE TRIALS; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INTRAVITREAL INJECTIONS; LASER THERAPY; MALE; NEOADJUVANT THERAPY; RETINOPATHY OF PREMATURITY; RETROSPECTIVE STUDIES; SALVAGE THERAPY;

EID: 84867489621     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2012.684109     Document Type: Article

References (30)

1. Drack AV. Preventing blindness in premature infants. N Engl J Med 1998;338:1620-1621. (Pubitemid 28243994)
2. Palmer EA, Flynn JT, Hardy RJ, Phelps DL, Phillips CL, Schaffer DB, Tung B. Incidence and early course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology 1991;98:1628-1640.
3. Hardy RJ, Good WV, Dobson V, Palmer EA, Phelps DL, Quintos M, Tung B; Early Treatment for Retinopathy of Prematurity Cooperative Group. Multicenter trial of early treatment for retinopathy of prematurity: study design. Control Clin Trials 2004;25:311-325. (Pubitemid 38626166)
4. Good W V, Hardy RJ, Dobson V, Palmer EA, Phelps DL, Quintos M, Tung B; Early Treatment for Retinopathy of Prematurity Cooperative Group. The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study. Pediatrics 2005;116:15-23.
5. Dani C, Reali MF, Bertini G, Martelli E, Pezzati M, Rubaltelli FF. The role of blood transfusions and iron intake on retinopathy of prematurity. Early Hum Dev 2001;62:57-63. (Pubitemid 32178136)
6. Dani C, Martelli E, Bertini G, Pezzati M, Rossetti M, Buonocore G, Paffetti P, Rubaltelli FF. Effect of blood transfusions on oxidative stress in preterm infants. Arch Dis Child Fetal Neonatal Ed 2004;89:F408-F411. (Pubitemid 39178816)
7. Smith LE. Pathogenesis of retinopathy of prematurity. Growth Horm IGF Res 2004;14 Suppl A:S140-S144. (Pubitemid 38701845)
8. Repka MX, Tung B, Good WV, Shapiro M, Capone A Jr, Baker JD, Barr CC, et al. Outcome of eyes developing retinal detachment during the early treatment for retinopathy of prematurity study (ETROP). Arch Ophthalmol 2006;124:24-30. (Pubitemid 43063885)
9. Gilbert WS, Quinn GE, Dobson V, Reynolds J, Hardy RJ, Palmer EA. Partial retinal detachment at 3 months after threshold retinopathy of prematurity. Long-term structural and functional outcome. Multicenter Trial of Cryotherapy for Retinopathy of Prematurity Cooperative Group. Arch Ophthalmol 1996;114:1085-1091.
10. Wu WC, Drenser KA, Lai M, Capone A, Trese MT. Plasmin enzyme-assisted vitrectomy for primary and reoperated eyes with stage 5 retinopathy of prematurity. Retina (Philadelphia, Pa) 2008;28:S75-S80. (Pubitemid 351644429)
11. Chen J, Smith LE. Retinopathy of prematurity. Angiogenesis 2007;10:133-140. (Pubitemid 46440629)
12. Mintz-Hittner HA, Kennedy KA, Chuang AZ; BEAT-ROP Cooperative Group. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med 2011;364:603-615.
13. International Committee for the Classification of Retinopathy of Prematurity. The international classification of retinopathy of prematurity revisited. Arch Ophthalmol 2005;124:1669-1670.
14. Ng EY, Lanigan B, O'Keefe M. Fundus fluorescein angiography in the screening for and management of retinopathy of prematurity. J Pediatr Ophthalmol Strabismus 2006;43:85-90.
15. Roohipoor R, Ghasemi H, Ghassemi F, Karkhaneh R, Riazi-Esfahani M, Nili-Ahmadabadi M. Intravitreal bevacizumab in retinopathy of prematurity: an interventional case series. Graefes Arch Clin Exp Ophthalmol 2011;249:1295-1301.
16. Travassos A, Teixeira S, Ferreira P, Regadas I, Travassos AS, Esperancinha FE, Prieto I, et al. Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity. Ophthalmic Surg Lasers Imaging 2007;38:233-237. (Pubitemid 46953791)
17. Shah PK, Narendran V, Tawansy KA, Raghuram A, Narendran K. Intravitreal bevacizumab (Avastin) for post laser anterior segment ischemia in aggressive posterior retinopathy of prematurity. Indian J Ophthalmol 2007;55:75-76. (Pubitemid 46065943)
18. Chung EJ, Kim JH, Ahn HS, Koh HJ. Combination of laser photocoagulation and intravitreal bevacizumab (Avastin) for aggressive zone I retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol 2007;245:1727-1730. (Pubitemid 47491565)
19. Lalwani GA, Berrocal AM, Murray TG, Buch M, Cardone S, Hess D, Johnson RA, Puliafito CA. Off-label use of intravitreal bevacizumab (Avastin) for salvage treatment in progressive threshold retinopathy of prematurity. Retina (Philadelphia, Pa) 2008;28:S13-S18. (Pubitemid 351644418)
20. Quiroz-Mercado H, Martinez-Castellanos MA, Hernandez-Rojas ML, Salazar-Teran N, Chan RV. Antiangiogenic therapy with intravitreal bevacizumab for retinopathy of prematurity. Retina (Philadelphia, Pa) 2008;28:S19-S25. (Pubitemid 351644419)
21. Mintz-Hittner HA, Kuffel RR Jr. Intravitreal injection of bevacizumab (avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II. Retina (Philadelphia, Pa) 2008;28:831-838.
22. Honda S, Hirabayashi H, Tsukahara Y, Negi A. Acute contraction of the proliferative membrane after an intravitreal injection of bevacizumab for advanced retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol 2008;246:1061-1063.
23. Kusaka S, Shima C, Wada K, Arahori H, Shimojyo H, Sato T, Fujikado T. Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot study. Br J Ophthalmol 2008;92:1450-1455.
24. Law JC, Recchia FM, Morrison DG, Donahue S P, Estes RL. Intravitreal bevacizumab as adjunctive treatment for retinopathy of prematurity. J AAPOS 2010;14:6-10.
25. Altinsoy HI, Mutlu FM, Güngör R, Sarici SU. Combination of laser photocoagulation and intravitreal bevacizumab in aggressive posterior retinopathy of prematurity. Ophthalmic Surg Lasers Imaging 2010;:1-:5.
26. Lee JY, Chae JB, Yang SJ, Yoon YH, Kim JG. Effects of intravitreal bevacizumab and laser in retinopathy of prematurity therapy on the development of peripheral retinal vessels. Graefes Arch Clin Exp Ophthalmol 2010;248:1257-1262.
27. Dorta P, Kychenthal A. Treatment of type 1 retinopathy of prematurity with intravitreal bevacizumab (Avastin). Retina (Philadelphia, Pa) 2010;30:S24-S31.
28. Kychenthal A, Dorta P. Vitrectomy after intravitreal bevacizumab (Avastin) for retinal detachment in retinopathy of prematurity. Retina (Philadelphia, Pa) 2010;30:S32-S36.
29. Harder BC, von Baltz S, Jonas JB, Schlichtenbrede FC. Intravitreal bevacizumab for retinopathy of prematurity. J Ocul Pharmacol Ther 2011;27:623-627.
30. Sato T, Wada K, Arahori H, Kuno N, Imoto K, Iwahashi-Shima C, Kusaka S. Serum concentrations of bevacizumab (avastin) and vascular endothelial growth factor in infants with retinopathy of prematurity. Am J Ophthalmol 2012;153:327-333.